Replies to post #1946 on RedHill Biopharma Ltd (RDHL)

[midastouch017]

RedHill’s Opaganib under compassionate use show objective clinical improvement; shares up 14% premarket

Apr. 27, 2020 8:50 AM ET|About: RedHill Biopharma Ltd. (RDHL)|By: Vandana Singh, SA News Editor
RedHill (NASDAQ:RDHL) jumps 13.9% in pre-market as Opaganib demonstrates measurable clinical improvement in all six moderate-to-severe COVID-19 patients treated.

Preliminary data show decreased requirement for supplemental oxygenation, higher lymphocyte counts and decreased CRP

Opaganib has been well tolerated and no patient required mechanical ventilation post the treatment with opaganib

IND had been submitted for a randomized clinical study in COVID-19 patients in the US, with clinical studies also planned in Israel and Italy.

https://seekingalpha.com/news/3564607-redhill-s-opaganib-under-compassionate-use-show-objective-clinical-improvement-shares-up-14?utm_medium=email&utm_source=seeking_alpha&mail_subject=rdhl-redhill-s-opaganib-under-compassionate-use-show-objective-clinical-improvement-shares-up-14-premarket&utm_campaign=rta-stock-news&utm_content=link-3

More exposure!

:-)